Table 4. Comparison of clinical features between male and female AAA patients.

Variables	Male (n = 289)	Female (n = 48)	P
Rupture, n (%)	26 (9.0%)	6 (12.5%)	0.428
Age, year	72.69 ± 9.99	76.21 ± 11.42	0.027
Diameter (cm)	4.81 ± 1.72	4.83±1.90	0.948
HbA1c (%)	6.09 ± 0.90	5.96 ± 0.69	0.400
LVEF (%)	59.11 ± 10.07	59.93 ± 9.68	0.617
cTnI (ng/ml)	1.02 ± 4.74	2.30 ± 7.10	0.309
BNP (pg/ml)	334.76 ± 781.04	581.56 ± 1,223.93	0.247
hsCRP (mg/ml)	53.81 ± 66.33	37.72 ± 52.18	0.206
Creatinine (mg/dL)	122.23 ± 96.73	117.55 ± 162.79	0.785
D-dimer (mg/L)	3.81 ± 4.49	5.46 ± 5.75	0.149
HDL-C (mmol/L)	1.10 ± 0.34	1.26 ± 0.44	0.020
LDL-C (mmol/L)	2.44 ± 0.94	2.57 ± 0.87	0.379
TG (mmol/L)	1.52 ± 1.23	1.79± 1.66	0.196
TC (mmol/L)	4.27 ± 1.17	4.91 ± 1.52	0.001
ApoA1 (g/L)	0.93 ± 0.22	1.06 ± 0.27	0.004
ApoB (g/L)	0.78 ± 0.25	0.81 ± 0.23	0.460
ApoB/ApoA1	0.89 ± 0.51	0.80 ± 0.27	0.234